Sales of Tamiflu in Moscow has increased six times due to flu epidemic

In the first three weeks of this year sales of anti-cold and anti-viral preparations in Moscow grew by 23% in value terms and 14 percent by volume, while overall pharmacy market of Moscow showed a drop of 3% in rubles and 6% in units, according to data of analytical company DSM Group, prepared especially for . The leader of the French demand was the drug “Tamiflu” during the first three weeks of January, sales rose almost six times compared to the same period last year to 33.5 million rubles Nearly four times increased sales oxolinic ointment — to 6.9 mln, “Anaferon” — on 56%, to 21.7 million rubles, “Arbidol” — on 20%, to 42,4 million rubles, and “Kagotsel” — 19%, to 57.8 million rubles.

Sales of pharmacy chain “Rigla” in January 2016 under a separate influenza and antiviral drugs has increased two to five times, confirms the Director of the marketing Department of the pharmacy network “Rigla” Natalia Burdina. Tamiflu is a leader in the growth of sales for the period increased by more than five times, she says. — In second place oxolinic ointment and protective masks. “Arbidol”, “Kagocel” and “Anaferon” has doubled its sales”.

This demand is within normal limits for the period of the outbreak, said Director of the Russian Association of pharmacy chains Nelli Ignatieva. According to her calculations, sales of antiviral drugs in Russia in January increased by 30% compared to previous months, when there was a virus outbreak.

On 25 January the chief sanitary doctor of Moscow Elena Andreeva has estimated the incidence of influenza and SARS in Moscow as an epidemic. “Vedomosti” wrote about the excessive demand for antiviral medications due to the increased incidence of influenza and SARS. On Wednesday last week, the head of the Moscow Department of health Alexei Khripun told journalists that Muscovites for the week were sold out a month’s supply of medical masks in pharmacies. In the majority of correspondents interviewed RNS pharmacies of Moscow and Moscow region at the end of last week it was impossible to buy medical masks, and some pharmacies were not “Tamiflu”, “Arbidol”, “Kagocel” and other antiviral drugs. In response to media reports about lack of medicines in the pharmacies of the Ministry of health reported that the shortage of antiviral drugs in Russia, but due to excessive demand at pharmacy chains arise “temporary logistical difficulties”.

One of the largest manufacturers of oxoline on the Russian market is the company Nizhpharm, a part of Stada CIS holding. Deputy General Director on development of Stada CIS Ivan Glushkov told that in January the sale of oxolinic ointment the company has grown five times in comparison with January of last year and amounted to 168 million rubles in Russia. “Oxolinic ointment high quality and inexpensive in retail price does not exceed 100 rubles.”, — Glushkov says.

The company “nearmedic”, the only manufacturer of “Plastic”, does not consider their own sales, and requests data of DSM, said the company representative. He noted that the asking price of “Kagocel” in the season of the epidemic has not changed. “Kagocel” included in the “list of vital and essential medicinal products”, and the price of the drug is regulated by the state within the limits of inflation”. In the Russian division of Roche (produces Tamiflu), “Pharmstandart” (produces “Arbidol”) and Materia Medica Holding (produces “Anaferon”) has not responded to the request .

Despite a significant increase in sales in January, the producers are not too hard to earn the hype, says development Director RNC Pharma Nikolay Bespalov. “At the scale of large companies it’s a penny, he says. — Roche for Tamiflu is not the key drug, the same can be said about oxolinic ointment for the company “Nizhfarm”. For “Nearmedic” and “Farmstandart” it’s more tangible sales, but on the “Arbidol” and “Kagocel” growth is not so high”. According to Stada, the top sales products of the company are “Levomekol” and “Vitaprost”. The best-selling Roche drugs in the world in 2013 were “Avastin” and “Herceptin”.

Earlier, representatives of pharmacy chains said that managed to increase their revenue in January due to the sales of antiviral drugs. Natalia Burdina last month, told “Vedomosti” that the proceeds of the third week of January to the second amounted to about 40% by categories anti-influenza and antiviral drugs. Vice-President of the group “Growth” (manages the pharmacy chain “rainbow”, “First aid”, etc.) Alexander Tarasov said earlier in the week that in January, the overall sales growth in pharmacies of the group amounted to 10-15% of the monthly rate periods, when there is no mass diseases. The increase in sales this January was higher than in previous years, he concluded.

According to DSM, the annual consumption of cold and flu and antiviral drugs and drugs that eliminate the symptoms, Russia is approximately 417 million packs, or about 90 billion rubles (the volume of sales in 2015).